David M Stack
CIK 1204788 · View on SEC EDGAR ↗
Insider
First SEC filing: Feb. 2, 2011 · Latest: Feb. 7, 2014
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 61 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
61 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 7, 2023 | PCRX | S | 5,326 | $37.86 | $201,642 | 153,781 Direct | -3.35% | Disposed | -35.2% (price as of 2026-08-19) |
| June 6, 2023 | PCRX | S | 5,058 | $38.99 | $197,211 | 159,107 Direct | -3.08% | Disposed | -37.1% (price as of 2026-08-19) |
| June 8, 2022 | PCRX | S 10b5-1 | 501 | $61.96 | $31,042 | 142,251 Direct | -0.35% | Disposed | -60.4% (price as of 2026-08-19) |
| June 8, 2022 | PCRX | S 10b5-1 | 1,282 | $61.31 | $78,599 | 142,752 Direct | -0.89% | Disposed | -60.0% (price as of 2026-08-19) |
| June 8, 2022 | PCRX | S 10b5-1 | 5,006 | $60.33 | $302,012 | 144,034 Direct | -3.36% | Disposed | -59.4% (price as of 2026-08-19) |
| June 8, 2022 | PCRX | S 10b5-1 | 7,039 | $59.10 | $416,005 | 149,040 Direct | -4.51% | Disposed | -58.5% (price as of 2026-08-19) |
| June 6, 2022 | PCRX | S 10b5-1 | 11,965 | $61.37 | $734,292 | 156,079 Direct | -7.12% | Disposed | -60.0% (price as of 2026-08-19) |
| June 4, 2021 | PCRX | S | 14,905 | $61.04 | $909,801 | 61,156 Direct | -19.60% | Disposed | -59.8% (price as of 2026-08-19) |
| June 4, 2021 | AMRN | P | 10,000 | $4.54 | $45,400 | 40,000 Indirect | +33.33% | Acquired | -84.2% (price as of 2026-08-19) |
| June 3, 2021 | AMRN | P | 5,000 | $4.62 | $23,100 | 30,000 Indirect | +20.00% | Acquired | -84.4% (price as of 2026-08-19) |
| May 12, 2021 | PCRX | S 10b5-1 | 3,611 | $62.41 | $225,363 | 76,061 Direct | -4.53% | Disposed | -60.7% (price as of 2026-08-19) |
| May 12, 2021 | PCRX | S 10b5-1 | 14,669 | $62.08 | $910,652 | 79,672 Direct | -15.55% | Disposed | -60.5% (price as of 2026-08-19) |
| May 12, 2021 | PCRX | S 10b5-1 | 2,970 | $60.76 | $180,457 | 94,341 Direct | -3.05% | Disposed | -59.6% (price as of 2026-08-19) |
| May 11, 2021 | PCRX | S 10b5-1 | 7,932 | $61.19 | $485,359 | 76,061 Direct | -9.44% | Disposed | -59.9% (price as of 2026-08-19) |
| May 11, 2021 | PCRX | S 10b5-1 | 13,318 | $60.78 | $809,468 | 83,993 Direct | -13.69% | Disposed | -59.7% (price as of 2026-08-19) |
| Feb. 3, 2021 | PCRX | S 10b5-1 | 14,350 | $71.42 | $1,024,877 | 76,061 Direct | -15.87% | Disposed | -65.7% (price as of 2026-08-19) |
| Feb. 3, 2021 | PCRX | S 10b5-1 | 6,900 | $70.78 | $488,382 | 90,411 Direct | -7.09% | Disposed | -65.4% (price as of 2026-08-19) |
| Feb. 2, 2021 | PCRX | S 10b5-1 | 4,100 | $70.20 | $287,820 | 76,061 Direct | -5.11% | Disposed | -65.1% (price as of 2026-08-19) |
| Feb. 2, 2021 | PCRX | S 10b5-1 | 14,250 | $69.38 | $988,665 | 80,161 Direct | -15.09% | Disposed | -64.7% (price as of 2026-08-19) |
| Feb. 2, 2021 | PCRX | S 10b5-1 | 2,900 | $68.41 | $198,389 | 94,411 Direct | -2.98% | Disposed | -64.2% (price as of 2026-08-19) |
| Nov. 30, 2020 | AMRN | P | 25,000 | $4.86 | $121,500 | 25,000 Indirect | — | Acquired | -85.2% (price as of 2026-08-19) |
| Oct. 16, 2020 | PCRX | S 10b5-1 | 30,000 | $55.56 | $1,666,800 | 173,377 Direct | -14.75% | Disposed | -55.9% (price as of 2026-08-19) |
| Oct. 15, 2020 | PCRX | S 10b5-1 | 30,000 | $55.00 | $1,650,000 | 173,377 Direct | -14.75% | Disposed | -55.4% (price as of 2026-08-19) |
| Oct. 14, 2020 | PCRX | S 10b5-1 | 30,000 | $55.53 | $1,665,900 | 173,377 Direct | -14.75% | Disposed | -55.8% (price as of 2026-08-19) |
| Aug. 17, 2020 | PCRX | S 10b5-1 | 3,217 | $62.34 | $200,548 | 173,377 Direct | -1.82% | Disposed | -60.7% (price as of 2026-08-19) |
| Aug. 17, 2020 | PCRX | S 10b5-1 | 11,783 | $61.79 | $728,072 | 176,594 Direct | -6.26% | Disposed | -60.3% (price as of 2026-08-19) |
| July 15, 2020 | PCRX | S 10b5-1 | 12,000 | $56.88 | $682,560 | 188,377 Direct | -5.99% | Disposed | -56.9% (price as of 2026-08-19) |
| June 8, 2020 | PCRX | S | 1,721 | $48.49 | $83,451 | 166,909 Direct | -1.02% | Disposed | -49.4% (price as of 2026-08-19) |
| June 8, 2020 | PCRX | S | 15,390 | $48.08 | $739,951 | 168,630 Direct | -8.36% | Disposed | -49.0% (price as of 2026-08-19) |
| June 4, 2020 | PCRX | S | 14,314 | $46.33 | $663,168 | 184,020 Direct | -7.22% | Disposed | -47.1% (price as of 2026-08-19) |
| Jan. 15, 2020 | PCRX | S 10b5-1 | 1,975 | $43.48 | $85,873 | 1,208 Indirect | -62.05% | Disposed | -43.6% (price as of 2026-08-19) |
| Jan. 15, 2020 | PCRX | S 10b5-1 | 23,025 | $42.61 | $981,095 | 3,183 Indirect | -87.85% | Disposed | -42.5% (price as of 2026-08-19) |
| Nov. 15, 2019 | PCRX | S 10b5-1 | 25,000 | $42.81 | $1,070,250 | 1,208 Indirect | -95.39% | Disposed | -42.7% (price as of 2026-08-19) |
| Nov. 15, 2019 | PCRX | S 10b5-1 | 45,000 | $42.81 | $1,926,450 | 142,299 Direct | -24.03% | Disposed | -42.7% (price as of 2026-08-19) |
| Aug. 15, 2019 | PCRX | S 10b5-1 | 2,391 | $39.61 | $94,708 | 156,299 Direct | -1.51% | Disposed | -38.1% (price as of 2026-08-19) |
| Aug. 15, 2019 | PCRX | S 10b5-1 | 10,458 | $39.05 | $408,385 | 158,690 Direct | -6.18% | Disposed | -37.2% (price as of 2026-08-19) |
| July 11, 2019 | AMRN | S 10b5-1 | 51,991 | $22.28 | $1,158,359 | 0 Indirect | -100.00% | Disposed | -96.8% (price as of 2026-08-19) |
| July 8, 2019 | PCRX | S 10b5-1 | 700 | $43.42 | $30,394 | 156,299 Direct | -0.45% | Disposed | -43.5% (price as of 2026-08-19) |
| July 8, 2019 | PCRX | S 10b5-1 | 12,415 | $42.85 | $531,983 | 156,999 Direct | -7.33% | Disposed | -42.8% (price as of 2026-08-19) |
Showing latest 100 of 271 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 14, 2023 | PCRX | Stock Option (Right to Buy) | Common Stock (245,400) | $38.74 | June 14, 2033 | 245,400 | Acquired |
| June 8, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (160,900) | $59.39 | June 8, 2032 | 160,900 | Acquired |
| April 28, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (22,500) | $10.81 | June 5, 2022 | 22,500 | Disposed |
| March 31, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (22,500) | $10.81 | June 5, 2022 | 22,500 | Disposed |
| Jan. 25, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (13,670) | $10.81 | June 5, 2022 | 13,670 | Disposed |
| Jan. 11, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $10.81 | June 5, 2022 | 15,000 | Disposed |
| Nov. 16, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $10.81 | June 5, 2022 | 15,000 | Disposed |
| June 9, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (133,400) | $60.96 | June 9, 2031 | 133,400 | Acquired |
| May 12, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (21,250) | $10.81 | June 5, 2022 | 21,250 | Disposed |
| May 11, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (21,250) | $10.81 | June 5, 2022 | 21,250 | Disposed |
| Feb. 3, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (21,250) | $10.81 | June 5, 2022 | 21,250 | Disposed |
| Feb. 2, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (21,250) | $10.81 | June 5, 2022 | 21,250 | Disposed |
| Oct. 16, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (30,000) | $10.81 | June 5, 2022 | 30,000 | Disposed |
| Oct. 15, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (30,000) | $10.81 | June 5, 2022 | 30,000 | Disposed |
| Oct. 14, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (30,000) | $10.81 | June 5, 2022 | 30,000 | Disposed |
| June 9, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (275,000) | $47.65 | June 9, 2030 | 275,000 | Acquired |
| Feb. 21, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (19,500) | $1.61 | Sept. 2, 2020 | 19,500 | Disposed |
| Feb. 21, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (16,356) | $5.49 | Dec. 29, 2020 | 16,356 | Disposed |
| Jan. 15, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (25,000) | $10.81 | June 5, 2022 | 25,000 | Disposed |
| Dec. 26, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (10,000) | $5.49 | Dec. 29, 2020 | 10,000 | Disposed |
| Dec. 26, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (10,000) | $1.61 | Sept. 2, 2020 | 10,000 | Disposed |
| Nov. 15, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (25,000) | $10.81 | June 5, 2022 | 25,000 | Disposed |
| Oct. 2, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (10,000) | $549.00 | Dec. 29, 2020 | 10,000 | Disposed |
| Oct. 2, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (7,000) | $1.61 | Sept. 2, 2020 | 7,000 | Disposed |
| Sept. 18, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (6,500) | $5.49 | Dec. 29, 2020 | 6,500 | Disposed |
| Sept. 18, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (7,500) | $1.61 | Sept. 2, 2020 | 7,500 | Disposed |
| Aug. 15, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (12,849) | $10.81 | June 5, 2022 | 12,849 | Disposed |
| July 11, 2019 | AMRN | Stock Option (Right to Buy) | Ordinary Shares (28,847) | $2.19 | July 11, 2026 | 28,847 | Disposed |
| July 11, 2019 | AMRN | Stock Option (Right to Buy) | Ordinary Shares (23,144) | $2.50 | July 6, 2025 | 23,144 | Disposed |
| June 11, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (9,000) | $5.49 | Dec. 29, 2020 | 9,000 | Disposed |
| June 11, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $1.61 | Sept. 2, 2020 | 15,000 | Disposed |
| June 5, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (142,100) | $43.54 | June 5, 2029 | 142,100 | Acquired |
| May 29, 2019 | AMRN | Stock Option (Right to Buy) | Ordinary Shares [F2] (33,799) | $3.21 | May 14, 2028 | 33,799 | Disposed |
| May 20, 2019 | AMRN | Restricted Stock Units | Ordinary Shares [F2] (7,428) | — | — | 7,428 | Acquired |
| May 20, 2019 | AMRN | Stock Option (Right to Buy) | Ordinary Shares [F2] (9,658) | $16.83 | May 20, 2029 | 9,658 | Acquired |
| May 17, 2019 | AMRN | Stock Option (Right to Buy) | Ordinary Shares [F2] (13,174) | $3.21 | May 14, 2028 | 13,174 | Disposed |
| Jan. 10, 2019 | AMRN | Stock Option (Right to Buy) | Ordinary Shares [F2] (11,572) | $2.50 | July 6, 2025 | 11,572 | Disposed |
| Jan. 10, 2019 | AMRN | Stock Option (Right to Buy) | Ordinary Shares [F2] (28,500) | $1.87 | March 11, 2024 | 28,500 | Disposed |
| Jan. 10, 2019 | AMRN | Stock Option (Right to Buy) | Ordinary Shares [F2] (13,500) | $5.58 | July 9, 2023 | 13,500 | Disposed |
| Jan. 10, 2019 | AMRN | Stock Option (Right to Buy) | Ordinary Shares [F2] (45,000) | $9.34 | Dec. 10, 2022 | 45,000 | Disposed |
| Jan. 10, 2019 | AMRN | Stock Option (Right to Buy) | Ordinary Shares [F2] (21,146) | $3.06 | May 15, 2027 | 21,146 | Disposed |
| Jan. 10, 2019 | AMRN | Stock Option (Right to Buy) | Ordinary Shares [F2] (5,786) | $2.50 | July 6, 2025 | 5,786 | Disposed |
| Dec. 18, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (6,000) | $5.49 | Dec. 29, 2020 | 6,000 | Disposed |
| Dec. 18, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (6,000) | $1.61 | Sept. 2, 2020 | 6,000 | Disposed |
| Oct. 11, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $5.49 | Dec. 29, 2020 | 15,000 | Disposed |
| Oct. 11, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (18,190) | $1.61 | Sept. 2, 2020 | 18,190 | Disposed |
| Oct. 11, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (11,810) | $1.61 | Sept. 2, 2020 | 11,810 | Disposed |
| Aug. 15, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (13,481) | $10.81 | June 5, 2022 | 13,481 | Disposed |
| Aug. 15, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (610) | $5.49 | Dec. 29, 2020 | 610 | Disposed |
| June 13, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (170,250) | $38.35 | June 13, 2028 | 170,250 | Acquired |
| May 15, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (10,000) | $10.81 | June 5, 2022 | 10,000 | Disposed |
| May 15, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $5.49 | Dec. 29, 2020 | 15,000 | Disposed |
| May 14, 2018 | AMRN | Restricted Stock Units | Ordinary Shares [F2] (31,153) | — | — | 31,153 | Acquired |
| May 14, 2018 | AMRN | Stock Option (right to buy) | Ordinary Shares [F2] (46,973) | $3.21 | May 14, 2028 | 46,973 | Acquired |
| Jan. 10, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (28,885) | $1.61 | Sept. 2, 2020 | 28,885 | Disposed |
| Nov. 15, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (28,885) | $1.61 | Sept. 2, 2020 | 28,885 | Disposed |
| Aug. 15, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (28,885) | $1.61 | Sept. 2, 2020 | 28,885 | Disposed |
| July 24, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $1.61 | Sept. 2, 2020 | 15,000 | Disposed |
| June 23, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $1.61 | Sept. 2, 2020 | 15,000 | Disposed |
| June 14, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (81,000) | $44.20 | June 14, 2027 | 81,000 | Acquired |
| May 15, 2017 | AMRN | Stock Option (right to buy) | Ordinary Shares [F2] (21,146) | $3.06 | May 15, 2027 | 21,146 | Acquired |
| May 15, 2017 | AMRN | Restricted Stock Units | Ordinary Shares [F2] (14,706) | — | — | 14,706 | Acquired |
| Jan. 17, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $5.49 | Dec. 29, 2020 | 15,000 | Disposed |
| Dec. 7, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (60,000) | $32.35 | Dec. 7, 2026 | 60,000 | Acquired |
| Nov. 15, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $5.49 | Dec. 29, 2020 | 15,000 | Disposed |
| Oct. 5, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (30,000) | $1.61 | Sept. 2, 2020 | 30,000 | Disposed |
| Aug. 15, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $5.49 | Dec. 29, 2020 | 15,000 | Disposed |
| July 11, 2016 | AMRN | Restricted Stock Units | Ordinary Shares [F2] (20,548) | — | — | 20,548 | Acquired |
| July 11, 2016 | AMRN | Stock Option (right to buy) | Ordinary Shares [F2] (28,847) | $2.19 | July 11, 2026 | 28,847 | Acquired |
| June 15, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (66,250) | $40.34 | June 15, 2026 | 66,250 | Acquired |
| April 15, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (25,000) | $5.49 | Dec. 29, 2020 | 25,000 | Disposed |
| Jan. 15, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $1.61 | Sept. 2, 2020 | 15,000 | Disposed |
| Oct. 15, 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $1.61 | Sept. 2, 2020 | 15,000 | Disposed |
| July 15, 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $1.61 | Sept. 2, 2020 | 15,000 | Disposed |
| July 6, 2015 | AMRN | Restricted Stock Units | Ordinary Shares [F2] (18,000) | — | — | 18,000 | Acquired |
| July 6, 2015 | AMRN | Restricted Stock Units | Ordinary Shares [F2] (40,500) | — | — | 40,500 | Acquired |
| July 6, 2015 | AMRN | Stock Option (right to buy) | Ordinary Shares [F2] (23,144) | $2.50 | July 6, 2025 | 23,144 | Acquired |
| July 6, 2015 | AMRN | Stock Option (right to buy) | Ordinary Shares [F2] (17,358) | $2.50 | July 6, 2025 | 17,358 | Acquired |
| April 15, 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (25,000) | $1.61 | Sept. 2, 2020 | 25,000 | Disposed |
| Jan. 15, 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $1.61 | Sept. 2, 2020 | 15,000 | Disposed |
| Oct. 15, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $1.61 | Sept. 2, 2020 | 15,000 | Disposed |
| Sept. 9, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (150,000) | $81.00 | June 3, 2024 | 150,000 | Acquired |
| Sept. 9, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (150,000) | $81.00 | June 3, 2024 | 150,000 | Disposed |
| Sept. 9, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (350,000) | $10.81 | June 4, 2022 | 350,000 | Acquired |
| Sept. 9, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (350,000) | $10.81 | June 4, 2022 | 350,000 | Disposed |
| July 15, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $1.61 | Sept. 2, 2020 | 15,000 | Disposed |
| June 3, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (150,000) | $81.00 | June 3, 2024 | 150,000 | Acquired |
| May 9, 2014 | PCRX | Employee Stock Option (Right to Buy) | Common Stock (25,000) | $1.61 | Sept. 2, 2020 | 25,000 | Disposed |
| March 11, 2014 | AMRN | Restricted Stock Units | Ordinary Shares [F2] (24,000) | — | — | 24,000 | Acquired |
| March 11, 2014 | AMRN | Stock Option (right to buy) | Ordinary Shares [F2] (28,500) | $1.87 | March 11, 2024 | 28,500 | Acquired |
| Dec. 30, 2013 | PCRX | Employee Stock Option (right to buy) | Common Stock (15,000) | $1.61 | Sept. 2, 2020 | 15,000 | Disposed |
| Sept. 30, 2013 | PCRX | Employee Stock Option (right to buy) | Common Stock (15,000) | $1.61 | Sept. 2, 2020 | 15,000 | Disposed |
| July 9, 2013 | AMRN | Stock Option (right to buy) | Ordinary Shares [F2] (13,500) | $5.58 | July 9, 2023 | 13,500 | Acquired |
| July 9, 2013 | AMRN | Restricted Stock Units | Ordinary Shares [F2] (9,000) | — | — | 9,000 | Acquired |
| June 28, 2013 | PCRX | Employee Stock Option (right to buy) | Common Stock (15,000) | $1.61 | Sept. 2, 2020 | 15,000 | Disposed |
| March 28, 2013 | PCRX | Employee Stock Option (right to buy) | Common Stock (15,000) | $1.61 | Sept. 2, 2020 | 15,000 | Disposed |
| Dec. 10, 2012 | AMRN | Stock Option (right to buy) | Ordinary Shares [F2] (45,000) | $9.34 | Dec. 10, 2022 | 45,000 | Acquired |
| June 5, 2012 | PCRX | Common Stock | Common Stock (350,000) | $10.81 | June 4, 2022 | 350,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Feb. 2, 2011 | PCRX | Common Stock | 18,600 | Indirect |
| Feb. 2, 2011 | PCRX | Stock Option (Right to Buy)→ Common Stock (185,960) | 185,960 | Direct |
| Feb. 2, 2011 | PCRX | Stock Option (Right to Buy)→ Common Stock (255,695) | 255,695 | Direct |
| Feb. 2, 2011 | PCRX | Stock Option (Right to Buy)→ Common Stock (158,466) | 158,466 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
PCRX
CEO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $941,387 | $720,600 | $1,266,798 | $3,909,786 | — | — | $39,520 | $6,878,091 |
| 2022 | $910,108 | $618,900 | $1,276,885 | $4,030,545 | — | — | $14,902 | $6,851,340 |
| 2019 | $831,966 | $624,675 | $1,088,181 | $3,244,433 | — | — | $17,173 | $5,806,428 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.